Neutropenia is a condition characterized by an abnormally low level of neutrophils, a type of white blood cell essential for fighting off infections. This reduction can result from various factors, including bone marrow disorders, autoimmune diseases, chemotherapy, or certain medications. Patients with neutropenia are at a heightened risk for infections, which can be serious or even life-threatening, making effective management crucial.
Treatment for neutropenia often involves addressing the underlying cause, as well as implementing supportive measures to prevent infections. Medications such as growth factors (e.g., filgrastim) can stimulate the production of neutrophils, while antibiotics may be prescribed to manage or prevent infections. Understanding neutropenia and its treatment options is vital for improving patient outcomes and enhancing quality of life, particularly for those undergoing cancer treatment or living with chronic conditions.